Molecular genetic studies in the past decade have demonstrated the enormous
genetic heterogeneity among the dominantly inherited ataxias. Mutations at
several distinct loci give rise to the progressive dominant ataxias and at
least 2 different mutations cause episodic ataxias with dominant inheritan
ce. The well-established genotypes for progressive dominant ataxias have al
l involved expansions of repeated CAG sequences. Clinically these patients
present with progressive cerebellar deficits as well as signs relating to p
athology in other neural systems in a variable fashion. Some of these other
signs serve as diagnostic clues to the underlying genotype, but the identi
fication of the genotype from the clinical phenotype alone is usually diffi
cult. The CAG expansions involved usually are unstable with intergeneration
al expansions as well as contractions of the repeat size. Phenotypic featur
es such as age of onset and to a lesser extent disease progression rate and
the presence of specific clinical signs depend on the CAG repeat size. Ide
ntification of the mutations has allowed precise genotypic diagnosis in sev
eral families allowing more accurate genetic counseling, including predicti
ve testing of at risk individuals when sought. Also, increasing information
about the gene products and their abnormal distributions in disease brain
is rapidly giving rise to rational ideas about the pathogenesis of neuronal
degeneration in these diseases and raising hope for meaningful treatment s
trategies.